Instructor in Medicine, Massachusetts General Hospital
Gastroenterology
Dr. Kathleen E. Corey, MD
|
|
Give Review
Kathleen Corey works in the field of Gastroenterology. She researched medicine at Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care She has 1 awards "Meaningful Use Stage 1 Certification". Doctor Kathleen E. Corey, MD is a published doctor and has 29 publications published. The lastest was: 'Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.' Kathleen Corey is registered with Medicare and accepts Medicare payments.
Publications
- Development and Validation of an Algorithm to Identify Nonalcoholic Fatty Liver Disease in the Electronic Medical Record.
- Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic Fatty liver Disease.
- Shear-Wave Elastography for the Estimation of Liver Fibrosis in Chronic Liver Disease: Determining Accuracy and Ideal Site for Measurement.
- Gaps in Recognition and Evaluation of Incidentally Identified Hepatic Steatosis.
- Prevalence and outcome of non-alcoholic fatty liver Disease in adolescents and young adults undergoing weight loss surgery.
- Obesity and liver Disease: the epidemic of the twenty-first century.
- Advanced Disease, Diuretic Use, and Marital Status Predict Hospital Admissions in an Ambulatory Cirrhosis Cohort.
- Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals with Nonalcoholic Fatty Liver Disease.
- Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.
- Metabolic Effects of Roux-en-Y Gastric Bypass in Obese Adolescents and Young Adults.
- Lipid Metabolite Profiling Identifies Desmosterol Metabolism as a New Antiviral Target for Hepatitis C Virus.
- Should combination therapy be the paradigm for future NASH clinical trials?
- Hepatocellular Carcinoma Screening Rates Vary by Etiology of Cirrhosis and Involvement of Gastrointestinal Sub-specialists.
- A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.
- Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up.
- Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.
- Treating difficult-to-treat hepatitis C virus infection: we may still need to push the ribavirin envelope.
- Outcomes and treatment of acute hepatitis C virus infection in a United States population.
- Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's Esophagus? A meta-analysis.
- Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile.
- Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis.
- Hepatitis B screening, prophylaxis and re-activation in the era of rituximab-based chemotherapy.
- Current status of therapy for hepatocellular carcinoma.
- The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C.
- Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis.
- Acute hepatitis C infection lowers serum lipid levels.
- Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation.
- The Absence of Obstructive Sleep Apnea May Protect against Non-Alcoholic Fatty Liver in Patients Undergoing Bariatric Surgery.
Schools
Duke University
Massachusetts General Hospital
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Massachusetts General Hospital -
Duke University School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1326174038 | |
| NPPES Provider LastName | COREY | |
| NPPES Provider FirstName | KATHLEEN | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 265.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326174038 |
| Last Name Of The Provider | COREY |
| First Name Of The Provider | KATHLEEN |
| View All |
Similar Doctors
|
|
Dr. Elizabeth S. Egan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew P. Wright, MD |
|
|
Dr. Sanjiv Chopra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine P. Cheney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily Rostholder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shilpa Grover, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David P. Nunes, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Joel B. Mason, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Moses Guelrud, MD
This Doctor is OpenDoctor Recommended.
|